Israel Active

United Hatzalah, Lahak Aviation and Sheba Medical Center together have launched a pilot service to bring cancer patients from remote parts of Israel to hospital for treatment. Previous dangerous and stressful 3–4-hour journeys are reduced to a safe, comfortable 40-minutes.

Pulmonary Embolism (PE) is the third leading cause of cardiovascular-related death and the number one cause of preventable hospital death. Israel’s Althea Medical is developing an over-the-wire medical device that physicians can use to remove blood clots quickly and safely from arteries in the lung.

EGFR inhibitors are common treatments for cancer but cause severe skin problems that cannot be fully alleviated. Israel’s EMRIS is developing a topical solution to block EGFRi monoclonal antibodies and allow the patient to continue treatment without the debilitating side effects.

Researchers at Israel's Sheba Medical Center and Intel have achieved 81% accuracy in predicting if biologic therapy would relieve a patient with Crohn’s Disease. They used machine-learning to analyze videos of complete capsule endoscopies (CE) of the small intestine.

Researchers at Haifa University have identified a blood test to diagnose patients who suffer from bipolar disorder. The test also can predict if the patient will respond to the most common treatment – Lithium carbonate. It can save misdiagnosis and wrong medication.

Israeli biotech ExoProTher is developing an anti-cancer therapy using protein generated from the p53 gene in the corneas of chickens. The foreign protein binds to cancerous human p53 protein, destroying tumors without side effects. The cornea is highly cancer resistant and full of p53 protein.

Israel’s Trisol Medical (see previously) has successfully implanted its new Transcatheter Tricuspid Valves in two US patients. The valve is called “forgotten” as the aortic and mitral valves get most medical attention. 10 Israelis have already had the implants.

Researchers at the Hebrew University of Jerusalem and Israel’s Technion Institute have created a tiny functioning human heart, smaller than a grain of rice. It will help scientists study the heart and develop new treatments for cardio-vascular diseases.  

Surgeons at Jerusalem’s Hadassah Ein Kerem detected twisted fallopian tubes in a fetus during a routine ultrasound of the mother. They immediately delivered the baby and performed a complex operation to save her ovaries.

Israeli NGOs IsraAID and Save A Child’s heart returned to South Sudan to assess children who needed heart surgery (see previously). They screened 74 children including 4-year-old Gladys who was in urgent need. Gladys was rushed to Israel for surgery.